Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts CHTP Hot Sheet
Join SI Premium – FREE
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- inTEST Corp (INTT) reported Q2 Revenue ; Offers Guidance
- Pioneer Bancorp (PBFS) Tops Q2 EPS by 14c
- Madrigal Pharma (MDGL) Tops Q2 EPS by 76c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
